Fidji Simo Steps Down from Full-Time OpenAI Role Due to Health

Fidji Simo, the executive responsible for OpenAI’s application and product business, has transitioned from her full-time position to a part-time advisory role. According to a statement released by Simo on X, the decision follows a three-month medical leave and a long-term struggle with a chronic autoimmune condition. Her move highlights the ongoing discussion regarding the sustainability of high-pressure leadership roles within the technology sector.

Transition to Advisory Role at OpenAI

Simo, who joined OpenAI in 2025 to lead the company’s operational business, confirmed that her health requires a shift in focus. While OpenAI CEO Sam Altman expressed support for her decision, the company has begun redistributing her responsibilities. During her initial three-month absence, Greg Brockman assumed her duties, and the company now plans to spread these operational tasks across multiple leadership members. This transition occurs as OpenAI continues preparations for a potential public offering, a process where Simo’s previous experience leading the IPO of Instacart was considered a significant asset.

The Impact of Chronic Illness on Tech Leadership

In her public announcement, Simo noted that her health challenges have persisted for seven years. She reflected on the difficulty of balancing executive demands with medical necessity, citing past advice from Meta CEO Mark Zuckerberg to prioritize long-term health—counsel she admitted to declining while overseeing the Facebook app. Simo’s transparency has sparked industry-wide discourse on the “always-on” culture of Silicon Valley.

“When I took medical leave, many people told me I was brave for prioritizing my health. In truth, I am making this decision now because I have failed to do so many times before,” Simo wrote. Her departure from a full-time capacity serves as a notable example of a senior leader choosing to adjust professional obligations to manage a chronic condition, rather than leaving the workforce entirely.

Professional Background and Industry Stakes

Simo’s career has been defined by high-profile roles at major technology firms. Her tenure includes:

• eBay: Served on the strategy team from 2007 to 2011.
• Meta (Facebook): Held the position of Vice President, overseeing the development of the Facebook app.
• Instacart: Appointed CEO in 2021, where she successfully led the company through its initial public offering.
• OpenAI: Joined in 2025 to oversee the product and application business, with a focus on scaling profitability.

Future Outlook for OpenAI Operations

The shift in Simo’s role leaves an operational gap as OpenAI faces pressure to demonstrate consistent profitability to investors ahead of a potential IPO. While Simo remains an advisor, the extent of her influence on product strategy remains to be seen. The company has not announced a successor for her specific executive title, opting instead for a collaborative distribution of her former portfolio. The situation remains a focal point for observers tracking how OpenAI manages its internal leadership transitions during a critical phase of organizational scaling.

Key Takeaways

• Role Change: Fidji Simo has moved from a full-time executive role at OpenAI to a part-time advisory position.
• Reasoning: The change is attributed to a chronic autoimmune condition that has affected the executive for seven years.
• Operational Impact: OpenAI is distributing Simo’s former responsibilities among existing leadership, including Greg Brockman.
• Broader Context: The move has initiated a public conversation regarding the intersection of health, chronic illness, and high-stakes executive performance in the tech industry.